Skip to main content
. 2014 Sep 21;10(10):1108–1115. doi: 10.7150/ijbs.9797

Figure 2.

Figure 2

A: SP600125 dose-response curves in endothelium-denuded aortas pre-contracted with 10-6 M phorbol 12,13-dibutyrate (PDBu, 10-6 M). All data are expressed as the mean ± SD (N = 5) and as the percentage of maximal contraction induced by 10-6 M PDBu. N indicates the number of rats from which the descending thoracic aortic rings were derived. *P < 0.001 versus the vehicle. †P < 0.01 and ‡P < 0.001 versus 10-6 M SP600125. #P < 0.001 versus 10-5 M SP600125. B: The effect of chelerythrine in endothelium-denuded aorta pre-contracted with 10-6 M dexmedetomidine (DMT). All data are expressed as the mean ± SD and as the percentage of maximal contraction induced by DMT (10-6 M), where N indicates the number of rat thoracic aortic rings: control, N = 7; 10-5 M chelerythrine, N = 7; 3 × 10-5 M chelerythrine, N = 7; *P < 0.05 and †P < 0.001 versus control, ‡P < 0.001 versus 10-5 M chelerythrine.